Information for "Mortality in antiepileptic drug development programs"
Jump to navigation
Jump to search
View the protection log for this page.
Basic information
| Display title | Mortality in antiepileptic drug development programs |
| Default sort key | Mortality in antiepileptic drug development programs |
| Page length (in bytes) | 2,542 |
| Page ID | 339 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
Page protection
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
Edit history
| Page creator | Ycarmen1 (talk | contribs) |
| Date of page creation | 08:08, 18 October 2017 |
| Latest editor | Alano (talk | contribs) |
| Date of latest edit | 13:42, 17 June 2019 |
| Total number of edits | 2 |
| Total number of distinct authors | 2 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |
Page properties
| Transcluded template (1) | Template used on this page:
|